Cargando…

Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A

Although Ma Huang Tang (MHT) has long been considered as a classical formula for respiratory infections like influenza, bronchitis and asthma, its chemical ingredients that really exert the main efficacy are still obscure. In this study we aimed to screen its antiviral components and investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wenyang, Du, Haixia, Shao, Chongyu, Zhou, Huifen, Lu, Yiyu, Yu, Li, Wan, Haitong, He, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747051/
https://www.ncbi.nlm.nih.gov/pubmed/31551774
http://dx.doi.org/10.3389/fphar.2019.00961
_version_ 1783451812199661568
author Wei, Wenyang
Du, Haixia
Shao, Chongyu
Zhou, Huifen
Lu, Yiyu
Yu, Li
Wan, Haitong
He, Yu
author_facet Wei, Wenyang
Du, Haixia
Shao, Chongyu
Zhou, Huifen
Lu, Yiyu
Yu, Li
Wan, Haitong
He, Yu
author_sort Wei, Wenyang
collection PubMed
description Although Ma Huang Tang (MHT) has long been considered as a classical formula for respiratory infections like influenza, bronchitis and asthma, its chemical ingredients that really exert the main efficacy are still obscure. In this study we aimed to screen its antiviral components and investigate the potential mechanisms. The MDCK cellular research results showed that, among nine predominant ingredients of MHT, L-methylephedrin (LMEP), L-ephedrine (LEP) and D-pseudo- ephedrine (DPEP) significantly inhibited the proliferation of influenza A virus in vitro, and the inhibitory effect at 24 h after the treatment was more obvious than that at 48 h. They also significantly inhibited the mRNA expression levels of related genes in the TLR3, TLR4 and TLR7 signaling pathways, which were accompanied with the down-regulation of TNF-α level and the up-regulation of IFN-β level in the cell supernatant. Therefore, three Ephedra alkaloids exert an antiviral effect in vitro which may be closely related to the inhibition of viral replication and the modulation of inflammatory response. Animal research further indicated, at the 3rd and 7th days after infection, LEP and DPEP significantly attenuated lung injury, decreased lung index, virus load in the lung and the level of IL-1β in serum, inhibited the mRNA expression levels of TNF-α, TLR3, TLR4, TLR7, MyD88, NF-κB p65 and RIG-1 as well as the protein expression levels of TLR4, TLR7, MyD88 and NF-κB p65 and markedly increased thymus index, the level of IL-10 in serum and the mRNA expression level of IFN-γ. LEP and DPEP have certain protective effects on the influenza virus-infected mice, which may be associated with their abilities of effectively alleviating lung injury, improving the immunologic function of infected mice and adjusting the host’s TLRs and RIG-1 pathways. The overall findings demonstrate that, as effective and inexpensive natural substances, Ephedra alkaloids and MHT may have potential utility in clinical management.
format Online
Article
Text
id pubmed-6747051
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67470512019-09-24 Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A Wei, Wenyang Du, Haixia Shao, Chongyu Zhou, Huifen Lu, Yiyu Yu, Li Wan, Haitong He, Yu Front Pharmacol Pharmacology Although Ma Huang Tang (MHT) has long been considered as a classical formula for respiratory infections like influenza, bronchitis and asthma, its chemical ingredients that really exert the main efficacy are still obscure. In this study we aimed to screen its antiviral components and investigate the potential mechanisms. The MDCK cellular research results showed that, among nine predominant ingredients of MHT, L-methylephedrin (LMEP), L-ephedrine (LEP) and D-pseudo- ephedrine (DPEP) significantly inhibited the proliferation of influenza A virus in vitro, and the inhibitory effect at 24 h after the treatment was more obvious than that at 48 h. They also significantly inhibited the mRNA expression levels of related genes in the TLR3, TLR4 and TLR7 signaling pathways, which were accompanied with the down-regulation of TNF-α level and the up-regulation of IFN-β level in the cell supernatant. Therefore, three Ephedra alkaloids exert an antiviral effect in vitro which may be closely related to the inhibition of viral replication and the modulation of inflammatory response. Animal research further indicated, at the 3rd and 7th days after infection, LEP and DPEP significantly attenuated lung injury, decreased lung index, virus load in the lung and the level of IL-1β in serum, inhibited the mRNA expression levels of TNF-α, TLR3, TLR4, TLR7, MyD88, NF-κB p65 and RIG-1 as well as the protein expression levels of TLR4, TLR7, MyD88 and NF-κB p65 and markedly increased thymus index, the level of IL-10 in serum and the mRNA expression level of IFN-γ. LEP and DPEP have certain protective effects on the influenza virus-infected mice, which may be associated with their abilities of effectively alleviating lung injury, improving the immunologic function of infected mice and adjusting the host’s TLRs and RIG-1 pathways. The overall findings demonstrate that, as effective and inexpensive natural substances, Ephedra alkaloids and MHT may have potential utility in clinical management. Frontiers Media S.A. 2019-09-10 /pmc/articles/PMC6747051/ /pubmed/31551774 http://dx.doi.org/10.3389/fphar.2019.00961 Text en Copyright © 2019 Wei, Du, Shao, Zhou, Lu, Yu, Wan and He http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wei, Wenyang
Du, Haixia
Shao, Chongyu
Zhou, Huifen
Lu, Yiyu
Yu, Li
Wan, Haitong
He, Yu
Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A
title Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A
title_full Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A
title_fullStr Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A
title_full_unstemmed Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A
title_short Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A
title_sort screening of antiviral components of ma huang tang and investigation on the ephedra alkaloids efficacy on influenza virus type a
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747051/
https://www.ncbi.nlm.nih.gov/pubmed/31551774
http://dx.doi.org/10.3389/fphar.2019.00961
work_keys_str_mv AT weiwenyang screeningofantiviralcomponentsofmahuangtangandinvestigationontheephedraalkaloidsefficacyoninfluenzavirustypea
AT duhaixia screeningofantiviralcomponentsofmahuangtangandinvestigationontheephedraalkaloidsefficacyoninfluenzavirustypea
AT shaochongyu screeningofantiviralcomponentsofmahuangtangandinvestigationontheephedraalkaloidsefficacyoninfluenzavirustypea
AT zhouhuifen screeningofantiviralcomponentsofmahuangtangandinvestigationontheephedraalkaloidsefficacyoninfluenzavirustypea
AT luyiyu screeningofantiviralcomponentsofmahuangtangandinvestigationontheephedraalkaloidsefficacyoninfluenzavirustypea
AT yuli screeningofantiviralcomponentsofmahuangtangandinvestigationontheephedraalkaloidsefficacyoninfluenzavirustypea
AT wanhaitong screeningofantiviralcomponentsofmahuangtangandinvestigationontheephedraalkaloidsefficacyoninfluenzavirustypea
AT heyu screeningofantiviralcomponentsofmahuangtangandinvestigationontheephedraalkaloidsefficacyoninfluenzavirustypea